Acute and recurrent thrombophlebitis continues to be a common disease with no evidence of a decrease in incidence over the last 25 years. Failure to establish a specific etiology has prevented the development of a successful plan of therapy. The recovery of organisms of bacterial L-form morphology, transitional forms and Sphaerophorus sp. (now classified as Bacteroides fragilis NGF) from a patient with thrombophlebitis was reported by Hill and Lewis in 1964 (Bacteriol. Proc., p. 48, 1964 ). Altemeier, Hill, and Fullen (1) subsequently showed an association between anaerobic, nonsporulating bacteria, and/or organisms of bacterial L-form morphology, and ideopathic thromboembolic disease.
Numerous reports describing thrombophlebitis in the clinical histories of patients with bacteroides infections (3, 8, 9, 13, 26, 27, 32, 34) tend to support the hypothesis that members of the bacteroides group (family Bacteroidaceae) and "cell wall-defective bacteria" (30) may play a significant role in the etiology of this disease. To determine whether these organisms indeed may be the etiologic agents of acute, recurrent, and ideopathic thrombophlebitis, we are investigating the mechanisms by which they may affect blood coagulation.
The present report describes the effects of lipopolysaccharide and lipid A of parent bacterial cells and a derived L-form of members of the Bacteroidaceae on blood coagulation in vivo and in vitro and compares these effects with those elicited by endotoxin and lipid A of Escherichia coli, Salmonella enteritidis, and Salmonella minnesota. Preliminary experiments to elucidate the mechanisms by which blood coagulation is affected also are reported. MATERIALS Preparation of lipopolysaccharide. The lipopolysaccharides (LPS) of Bacteroides sp. X-508 and F. mortiferum 9817, bacterial and L-form, were prepared by the method of Westphal (24) . LPS prepared from the anaerobes were free of detectable 2-keto-3-deoxyoctonate (KDO), when assayed by the method of Waravdekar (35) . E. coli strain 055: B5 and S. enteritidis LPS W were obtained from Difco Laboratories, Detroit, Mich. LPS of Sphaerophorus necrophorus and B. fragilis were kindly provided by Otto Liideritz, Max-Plank Institute fur Immunobiologie, Freiburg, Germany.
Preparation of lipid A. The method of Galanos et al. (10) was used for the preparation of' untreated and alkaline-treated lipid A. KDO was not detectable in these preparations (35) . Alkaline-treated lipid A was used in all experiments. Similar results were obtained with untreated lipid A and lipid A complexed with bovine serum albumin (12) .
Platelet and leukocyte counts. Platelet counts were performed by the method of Brecher and Cronkite (5) . The counts were performed on citrated rabbit blood, obtained by cardiac puncture and on mouse blood drawn from the retroorbital sinus in heparinrinsed (50 U/ml of' heparin) capillary tubes (ClayAdams, Inc., N.Y.). The mouse blood was expelled into an equal volume of ethylenediaminetetraacetate (EDTA) solution (7.5 mg of EDTA/ml), and platelets were enumerated. For leukocyte determinations, citrated rabbit blood was diluted in Turk solution and leukocytes were counted on a hemocytometer.
In vitro platelet aggregation. Clotting time of recalcified human and rabbit plasma. A mixture of 0.075 ml of noncontacted, platelet-deficient, citrated human plasma, 0.025 ml of the preparation to be tested, and 0.1 ml of chloroform extract of brain (platelet factor reagent, BBL) contained in a polystyrene tube (12 by 75 mm, no. 2052; Falcon Plastics) was incubated at 37 C for 4 min. A 0.1-ml amount of 0.025 M calcium chloride was then added to the reaction mixture and the tube was tilted once a minute until clotting occurred (4). The clotting time of recalcified platelet-poor, citrated, C6-deficient rabbit plasma was performed in a similar fashion. The To determine if the LPS of Bacteroides sp. would induce a generalized Schwartzman reaction, two appropriately spaced doses (28) , each containing 1,500 ,g of LPS, were injected into a rabbit. At 120 min after the second injection of Bacteroides sp. LPS, an acceleration of blood clotting, without a concomitant decrease in platelets or leukocytes, was observed (Table 4) . Injection of two appropriately spaced doses of E. coli LPS resulted in a decrease in leukocyte and platelet counts and a lengthening of clotting time (Table 4) , which was consistent with changes previously reported during the generalized Schwartzman reaction (28) .
Since it has been demonstrated that different mechanisms are involved in the aggregation of nonprimate and human platelets, the effect of Bacteroidaceae LPS and lipid A preparations on the aggregation of human platelets was also plasma samples. LPS of Bacteroides sp., F. mortiferum, bacterial and L-form, S. necrophorus, and B. fragilis significantly (P = <0.001) shortened the clotting time of recalcified human plasma, whereas the LPS of E. coli had no effect. Lipid A preparations of all the microorganisms significantly (P = <0.001) accelerated in vitro coagulation ( Table 6 ). The LPS and lipid A of F. mortiferum, bacterial and L-form, significantly shortened the clotting time of platelet-poor, C6-deficient rabbit plasma. In contrast, the lipid A, but not the LPS, of E. coli accelerated coagulation in this system ( Table 7) . Effect of S. minnesota wild type and R595 on coagulation and circulating platelets. Intravenous injection of washed cells of S. minnesota R595 into mice significantly (P --<0.001) shortened the whole blood clotting time; the wild-type S. minnesota had no effect on mouse blood clotting time after intravenous injection (Table 8 ). Washed cells of S. minnesota R595 also significantly (P = <0.001) shortened the clotting time of recalcified, platelet-deficient, normal human plasma, whereas washed cells of the wild-type S. minnesota had no effect in this system (Table 8) . Intravenous injection of washed cells of the wild-type S. minnesota into mice resulted in a significant (P = <0.001) reduction in circulating platelet counts 120 min after injection; S. minnesota R595 washed cells had no detectable effect on circulating platelet counts at an identical time interval after injection (Table 8) .
DISCUSSION
The most significant findings of this investigation were that Bacteroides sp. and the bacterial form and L-form of F. mortiferum accelerated blood coagulation by a mechanism which did not require platelets and that this clot-promoting activity appeared to be dependent upon the lipid A moiety of their LPS. The methods for demonstrating in vivo acceleration of coagulation were the capillary microclotting time technique in mice and the Lee-White clotting time in rabbits. These methods, although somewhat insensitive, demonstrated a significant acceleration of coagulation in these animals by whole bacterial cells, LPS, and lipid A preparations of the microorganisms. During the time in which coagulation in these animals was accelerated by LPS and lipid A, no decrease in the number of circulating platelets was observed.
The effect of Bacteroides sp. and F. mortiferum LPS and lipid A on platelets deviated markedly from that observed with the LPS of E. coli. Whereas LPS and lipid A of the anaerobic gram-negative microorganisms accelerated coag ulation without affecting circulating platelets in nonprimates, a concomitant acceleration of coagulation and decrease in platelets was observed when E. coli LPS was injected into these animals. Moreover, although E. coli LPS resulted in aggregation of human platelets in vitro, LPS and lipid A of Bacteroides sp. and F. mortiferum had no effect in this experimental system. Since it has been shown that lysis of human platelets is mediated by an IgG receptor (25) , the inability of cell wall components of the anaerobic microorganisms to aggregate human platelets may have been due to the absence of "natural" antibodies in the platelet-rich plasma used in the experimental system. However, preliminary studies indicate that antibodies to these cell wall components are present in the sera of normal individuals indicating that a more plausible explanation for these results is that the cell wall components were unable to cause platelet aggregation in the presence of sufficient "natural" antibodies.
The observed differences in the clot-promoting activities of the LPS of aerobic and anaerobic microorganisms may be related to their structural or conformational arrangement. The LPS of gram-negative aerobic microorganisms, such as E. coli, contain heptose as a basal sugar of the LPS core and KDO which serves as a link between the polysaccharide and lipid A moieties of the LPS. These LPS have also been shown to be highly toxic to laboratory animals.
In contrast, the LPS of Bacteroides sp. and F. mortiferum did not contain KDO and were found to be nontoxic to laboratory animals, which confirms the observations of Hofstad, who has reported similar findings (15, 17) . Although these LPS appear to be nontoxic, it has The arrangement of the LPS in these microorganisms may be such that the lipid A moiety is more readily exposed due to the absence of KDO and therefore able to act upon coagulation mechanisms. In contrast, the differences in the coagulation effects of E. coli LPS and lipid A suggest that the polysaccharide moiety may mask sites on the lipid A which are responsible for platelet-independent coagulation effects. The finding that lipid A of E. coli accelerated coagulation by a similar mechanism supports this hypothesis. Also, the observation that S. minnesota R595, a mutant whose cell wall LPS contains only lipid A and KDO (11), accelerated coagulation in vivo and in vitro but did not cause platelet aggregation lends further evidence that appropriately exposed lipid A may be capable of accelerating coagulation. Experiments are now in progress to delineate the immunochemical and chromatographic characteristics of cell wall components of these anaerobic microorganisms.
The results of these studies confirm those of other investigators who have shown that LPS of aerobic gram-negative microorganisms caused marked platelet aggregation in vivo and in vitro (8, 23, 28, 29) and had no effect on the clotting time of platelet-free human or rabbit plasma (23, 29) . Platelet aggregation in rabbits induced by LPS of aerobic gram-negative microorganisms has been shown to depend primarily upon a complement-mediated LPS-platelet interac- (36, 37) . The events include fixation of C3 to the LPS followed by immune adherence of platelets to the fixed C3 and a intense platelet factor 3 (PF3) activation which appears to be due to the reactive lysis of platelets (25) .
Washed cells, LPS, and lipid A of Bacteroides sp., F. mortiferum, B. fragilis, and S. necrophorus also significantly accelerated the recalcified clotting time of platelet-poor normal human and C6-deficient rabbit plasma, in the presence of a constant source of platelet phospholipid, chloroform extract of brain. These observations suggested that cell wall components of the anaerobic microorganisms activated or accelerated one of the large number of coagulation interactions which occur during the formation of fibrin, and did not require terminal components of complement for their clot-promoting activity.
Although our results do not elucidate the mechanism by which the LPS and lipid A of the anaerobic microorganisms accelerate coagulation, several possibilities are under investigation. These compounds may act as a platelet phospholipid substitute, on prothrombin-tothrombin conversion, or directly on the fibrinogen-to-fibrin reaction, or may activate one of the clotting factors. Based on the structure of lipid A, the most likely mode of action of the molecule appears to be the direct activation of one of the clotting factors. Lipid A is a glucosaminyl-f,-1, 6-glucosamine disaccharide with the hydroxyl groups, except at the 3' position, substituted by the long-chain fatty acids, lauric, myristic, palmitic, and,3-hydroxymyristic (11, 12) . Long-chain fatty acids have been demonstrated to accelerate coagulation by the activation of factors XI, XII, or both (7). The interesting findings of Zimmerman and MillerEberhard indicate that activators of Hageman factor (factor XII) can initiate clotting in the absence of an intact complement system (37).
The incidence of the isolation of Bacteroidaceae from patients with thromboembolic disease suggests that these organisms may play a role in the etiology of the disease. Our findings that the microorganisms significantly accelerate coagulation support this hypothesis. Although the lipid A moiety appears to be essential in the observed acceleration of coagulation, the participation of factors other than cell wall components in the acceleration of coagulation cannot be excluded. In this regard Gesner and Jenkins have demonstrated that a Bacteroides sp. isolated from human feces was capable of degrading heparin (14) . We The methods which exist for determining hypercoagulability are far from refined, and we hesitate to suggest that our results may indicate that the Bacteroidaceae cause a hypercoagulable state in vivo by the proposed mechanism. Further experimentation and refined methodology will have to be utilized before this hypothesis can be substantiated.
